White Paper

The Future Is Now: Cell And Gene Therapy Innovation, Challenges, And Perspectives

Source: Precision ADVANCE
GettyImages-1288118586 cell development

The rising number of cell and gene therapies advancing toward clinical trials and eventual commercialization hold the potential to treat a number of diseases with previously unmet needs. With six new therapies approved in 2022, including the first allogeneic T-cell therapy, and at least as many slated for approval this year, the sector is poised for rapid growth.

However, many challenges remain in this nascent industry. Developers must provide innovative solutions to navigate the shifting regulatory landscape and employ efficient, reliable manufacturing processes to reduce costs and ensure product efficacy. Review the white paper to learn more about the challenges – such as gene insertion and immunogenicity – that hinder advancement as well as exciting possibilities for expanded applications in the future.

access the White Paper!

Get unlimited access to:

Trend and Thought Leadership Articles
Case Studies & White Papers
Extensive Product Database
Members-Only Premium Content
Welcome Back! Please Log In to Continue. X

Enter your credentials below to log in. Not yet a member of Advancing RNA? Subscribe today.

Subscribe to Advancing RNA X

Please enter your email address and create a password to access the full content, Or log in to your account to continue.


Subscribe to Advancing RNA